HHQ16

Overview

HHQ16 is an orally active derivative of Astragaloside IV ( HY-N0431 ). HHQ16 effectively reverses infarction-induced hypertrophy and heart failure by targeted degrading lnc4012/lnc9456 and antagonizing their effects on G3BP2/NF-κB signaling.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Others | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Drug Derivative

Product Information

• Catalog No.: HY-160706
• CAS No.: 2620471-66-9
• Molecular Formula: C30H48F2O4
• Molecular Weight: 510.70
• Purity: 99.97%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.5 mg/mL (4.90 mM); Clear solution
• Availability: In-stock

Source

Original product source